Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4Recruiting 3Completed 2Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 20Thoracic 9Other solid neoplasm 9Breast 7Gynecologic 5Sarcoma 3Head & Neck 3Plasma cell 2Other hematologic neoplasm 2Tumor-Agnostic 1Lymphoid 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Advanced Extrapulmonary Neuroendocrine Cancer 1

Interventions

Observation 2Interviews as Topic 2Fluorouracil 2Carboplatin 2Adrenalectomy 2zimberelimab 1trametinib 1lutetium Lu 177 dotatate 1dabrafenib 1cemiplimab 1apatinib 1anlotinib 1Watchful Waiting 1Thyroxine 1Surveys and Questionnaires 1Standard of Care 1Radiomics 1Radiation 1Positron Emission Tomography Computed Tomography 1Mitoxantrone 1Leucovorin 1Irinotecan 1Injections 1IFL protocol 1Etoposide 1Engineering 1Endoscopic Mucosal Resection 1Decision Support Techniques 1Counseling 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Injections × Endocrine × Clear all
NCT06951243 2025-04-30

A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

Beijing GoBroad Hospital

Phase 2 Not yet recruiting
40 enrolled
Endocrine

Advanced Extrapulmonary Neuroendocrine Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡